162 related articles for article (PubMed ID: 27307001)
41. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
42. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
43. Whole-body MRI in patients with Non-bacterial Osteitis: Radiological findings and correlation with clinical data.
Arnoldi AP; Schlett CL; Douis H; Geyer LL; Voit AM; Bleisteiner F; Jansson AF; Weckbach S
Eur Radiol; 2017 Jun; 27(6):2391-2399. PubMed ID: 27663226
[TBL] [Abstract][Full Text] [Related]
44. Application of whole-body MRI to detect the recurrence of lung cancer.
Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
[TBL] [Abstract][Full Text] [Related]
45. Whole-body MRI for primary evaluation of malignant disease in children.
Krohmer S; Sorge I; Krausse A; Kluge R; Bierbach U; Marwede D; Kahn T; Hirsch W
Eur J Radiol; 2010 Apr; 74(1):256-61. PubMed ID: 19278802
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
[TBL] [Abstract][Full Text] [Related]
48. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
Mosavi F; Laurell A; Ahlström H
Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
[TBL] [Abstract][Full Text] [Related]
49. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
50. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer.
Usuda K; Sagawa M; Maeda S; Motono N; Tanaka M; Machida Y; Matoba TM; Watanabe N; Tonami H; Ueda Y; Uramoto H
Asian Pac J Cancer Prev; 2016; 17(6):2775-80. PubMed ID: 27356689
[TBL] [Abstract][Full Text] [Related]
52. Typical patterns of bone involvement in whole-body MRI of patients with chronic recurrent multifocal osteomyelitis (CRMO).
von Kalle T; Heim N; Hospach T; Langendörfer M; Winkler P; Stuber T
Rofo; 2013 Jul; 185(7):655-61. PubMed ID: 23696017
[TBL] [Abstract][Full Text] [Related]
53. Whole-body MRI in generalized cystic lymphangiomatosis in the pediatric population: diagnosis, differential diagnoses, and follow-up.
Herruela-Suffee C; Warin M; Castier-Amouyel M; Dallery F; Bonnaire B; Constans JM
Skeletal Radiol; 2016 Feb; 45(2):177-85. PubMed ID: 26545884
[TBL] [Abstract][Full Text] [Related]
54. Whole-body MRI for preventive health screening in a general population: Prevalence of incidental findings around the hip.
Na Kim J; Jin Park H; Yeon Won S; Kim M; Woo Hong S; Kim E; Jin Park S; Taek Lee Y
Eur J Radiol; 2022 May; 150():110239. PubMed ID: 35290908
[TBL] [Abstract][Full Text] [Related]
55. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
[TBL] [Abstract][Full Text] [Related]
56. Role of whole-body magnetic resonance imaging in the evaluation of extrapulmonary tuberculosis in immunocompetent patients.
Pandey AK; Gupta RK; Jain KK; Prakash N; Vasdev N; Raj RK; Roy B; Patir R
J Comput Assist Tomogr; 2014; 38(3):415-23. PubMed ID: 24681855
[TBL] [Abstract][Full Text] [Related]
57. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study.
Littooij AS; Kwee TC; de Keizer B; Bruin MC; Coma A; Beek FJ; Fijnheer R; Nievelstein RA
J Magn Reson Imaging; 2015 Dec; 42(6):1646-55. PubMed ID: 25952024
[TBL] [Abstract][Full Text] [Related]
58. Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications.
Petralia G; Padhani AR
Magn Reson Imaging Clin N Am; 2018 Nov; 26(4):495-507. PubMed ID: 30316463
[TBL] [Abstract][Full Text] [Related]
59. Incidental findings in healthy control research subjects using whole-body MRI.
Morin SH; Cobbold JF; Lim AK; Eliahoo J; Thomas EL; Mehta SR; Durighel G; Fitzpatrick J; Bell JD; Taylor-Robinson SD
Eur J Radiol; 2009 Dec; 72(3):529-33. PubMed ID: 18818038
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
